Loading your page…
Pharmaceutical group · United States
A group of 6 companies with 50 medicines in 2 countries.
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 50
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLISTIN4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Carbinoxamine | United States | Not marketed | |
| DIENESTROL0.01% · Cream | Dienestrol | United States | Not marketed | 1947 |
| DITROPAN5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Syrup | Oxybutynin | United States | Not marketed | 1979 |
| FLOXIN20mg/ml | 40mg/ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| FLOXIN IN DEXTROSE 5%400mg/100ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER400mg/100ml | 4mg/ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| HALDOL2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Concentrate | Haloperidol | United States | Not marketed | 1967 |
| HALDOL0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register d · Tablet | Haloperidol | United States | Not marketed | 1967 |
| HALDOL SOLUTAB1MG · Tablet | Haloperidol | United States | Not marketed | |
| INJECTAPAP100mg/ml · Injectable | Paracetamol | United States | Not marketed | |
| MODICON 210.035MG; 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1974 |
| NORCEPT-E 1/35 210.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1989 |
| NORCEPT-E 1/35 280.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1989 |
| ORTHO-NOVUM 1/35-210.035MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1974 |
| ORTHO-NOVUM 1/50 210.05mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 1/50 280.05mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1968 |
| ORTHO-NOVUM 1/80 210.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | |
| ORTHO-NOVUM 1/80 280.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | |
| ORTHO-NOVUM 10/11-210.035MG,0.035MG; 0.5MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1982 |
| ORTHO-NOVUM 10/11-280.035mg,0.035mg; 0.5mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1982 |
| ORTHO-NOVUM 10-210.06mg; 10mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 2-210.1mg; 2mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 7/14-210.035MG,0.035MG; 0.5MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1984 |
| ORTHO-NOVUM 7/14-280.035MG,0.035MG; 0.5MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1984 |
| ORTHO TRI-CYCLEN 210.035mg,0.035mg,0.035mg; 0.18mg,0.215mg,0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2005 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 47 | 47 | 0 | CompaniesAll medicines |
| Canada | 3 | 0 | 3 | CompaniesAll medicines |
Also in the registers of Brazil
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.
